×

Strategic Realignment of Texas Research and Development Incentives: Addressing the 2026 Sales Tax Exemption Sunset

Author: Arooj Ajmal | Texas R&D Tax Policy Consultant (Swanson Reed Texas)
Published: July 1, 2026 | Updated: July 28, 2026 | Series: Swanson Reed State Tax Incentives

Answer Capsule: How Does Senate Bill 2206 Impact Texas R&D Incentives?

Senate Bill 2206 marks a profound structural shift for Texas innovators effective January 1, 2026. While the legislation establishes a highly competitive 8.722% Subchapter T franchise tax credit aligned with federal QRE definitions, it concurrently repeals the immediate sales tax exemption for R&D equipment (Sec. 151.3182). This forces capital-intensive startups to pay upfront sales tax, resulting in a 12-to-18-month “liquidity trap” until credits can be refunded. Addressing this temporal disconnect through an Accelerated Refund Program or Deferral Certificates is critical to maintaining Texas’s economic vitality.

Key Takeaways

  • The 2026 Policy Pivot: SB 2206 streamlines the Texas tax code by consolidating R&D incentives into an enhanced Subchapter T franchise tax credit while entirely eliminating the point-of-sale tax exemption.
  • The Liquidity Trap: Asset-heavy industries (Biotechnology, Aerospace, Semiconductors) are disproportionately harmed. They must now absorb 6.25%–8.25% in upfront equipment taxes, stalling non-dilutive capital.
  • Federal Alignment & Refundability: Texas now pegs state QRE definitions to IRS Form 6765, radically lowering compliance friction. New provisions also offer credit refundability for entities with revenue under $2.47 million.
  • Proposed Solutions: The implementation of a Texas R&D Accelerated Refund Program (TARP) allowing quarterly refunds, or targeted Sales Tax Deferral Certificates, could restore startup liquidity while preserving state audit integrity.
  • Macroeconomic ROI: Economic modeling indicates that for every $1 of foregone tax revenue deployed through R&D incentives, Texas yields $12.47 in Gross State Product (GSP) over 20 years.

Introduction: The Transition of the “Texas Miracle”

The economic vitality of the State of Texas has long been predicated on a policy environment that favors capital investment, technological innovation, and a streamlined regulatory burden. Central to this “Texas Miracle” has been the robust framework of incentives designed to attract and retain high-growth industries, particularly in the fields of biotechnology, aerospace, semiconductors, and advanced manufacturing. However, as the state transitions into a new era of fiscal administration under the provisions of Senate Bill 2206, enacted during the 89th Legislative Session, a significant structural shift is poised to occur on January 1, 2026.

The repeal of the immediate sales and use tax exemption for research and development (R&D) equipment, codified in Texas Tax Code Section 151.3182, and its replacement with a deferred, though enhanced, franchise tax credit under the new Subchapter T, creates a critical liquidity challenge for small to medium-sized businesses (SMBs) and early-stage startups.

This whitepaper provides a comprehensive analysis of the policy issue, examining the historical evolution of Texas R&D incentives, the technical mechanics of the 2026 transition, and the resulting cash flow burdens placed upon capital-intensive ventures. It further proposes two practical legislative solutions aimed at restoring immediate liquidity while maintaining the state’s rigorous standards for fraud prevention and fiscal accountability. By framing the initial revenue outlay as a strategic investment in the state’s future tax base, this report demonstrates how targeted policy adjustments will ultimately pay for themselves through increased Gross State Product (GSP) and high-wage job creation.

The Evolution of the Texas Research and Development Incentive Framework

To understand the magnitude of the 2026 policy change, one must first examine the dual-track incentive system that has governed the state’s innovation economy since 2014. Established via House Bill 800 in the 83rd Legislative Session, the existing framework was designed to provide flexibility to a diverse range of taxable entities. Under the current law, which remains in effect until December 31, 2025, businesses engaged in qualified research are permitted to claim either a franchise tax credit based on their qualified research expenses (QREs) or a sales and use tax exemption on the purchase, lease, or storage of depreciable tangible personal property directly used in R&D activities.

The Bifurcated Policy Strategy (2014–2025)

The logic behind the dual-track system was rooted in the differing financial profiles of established corporations and emerging startups. Large, profitable entities with substantial operations in Texas typically utilized the Subchapter M franchise tax credit to offset their state margin tax liability. This credit, generally calculated as 5% of the excess of current-year QREs over a three-year base period, provided a significant year-end tax reduction for companies with consistent R&D pipelines.

Conversely, early-stage SMBs—which often operate at a net loss during their initial years of experimentation—found the sales tax exemption far more impactful. Because these entities frequently have no franchise tax liability to offset, the ability to avoid paying a 6.25% state sales tax (plus up to 2% in local taxes) at the point of purchase provided immediate, non-dilutive capital. For a biotechnology startup acquiring $2 million in laboratory equipment, this exemption represented an immediate $165,000 in cash savings that could be redeployed into hiring specialized researchers or purchasing additional supplies.

Incentive Component Statutory Authority Primary Mechanism Benefit Timing
Franchise Tax Credit Tax Code Ch. 171, Subchapter M 5% of incremental QREs against margin tax Annual (at time of filing)
Sales Tax Exemption Tax Code Sec. 151.3182 Full exemption on depreciable R&D property Immediate (at point of sale)
University Credit Tax Code Ch. 171, Subchapter M 6.25% credit for university-contracted R&D Annual (at time of filing)
Carryforward Tax Code Sec. 171.659 20-year window for unused credits Long-term

Administrative Challenges and the Path to SB 2206

While the dual-track system was effective in attracting investment, it was not without administrative friction. The Texas Comptroller of Public Accounts noted that managing two distinct sets of criteria—one for “qualified research” under the franchise tax and another for “depreciable property used in research” under the sales tax—led to significant compliance burdens for both the state and the taxpayer. Furthermore, the Texas definition of QREs under Subchapter M occasionally diverged from the federal standards found in Internal Revenue Code (IRC) Section 41, leading to costly and time-consuming audits where taxpayers were required to substantiate their innovation threshold twice.

In response to these inefficiencies, the 89th Legislature passed Senate Bill 2206, signed by Governor Greg Abbott in June 2025. This landmark legislation seeks to streamline the state’s innovation policy by consolidating incentives into a single, permanent, and more robust franchise tax credit framework under Subchapter T. However, the cost of this streamlining was the total repeal of the Section 151.3182 sales tax exemption, effective January 1, 2026.

The 2026 Policy Pivot: Mechanics of Subchapter T

The new Subchapter T framework represents a fundamental shift toward performance-based incentives. By increasing the credit rate and aligning state definitions with federal law, the legislature aimed to make Texas more competitive with other technology hubs like California and Michigan.

Enhanced Rates and Federal Alignment

Starting in the 2026 reporting year, the base R&D credit rate increases from 5% to 8.722% of the difference between current-period QREs and 50% of the average QREs from the preceding three years. For companies that have no history of R&D in Texas, a standard base rate of 4.361% applies to all current-year expenses. Perhaps most importantly for administrative efficiency, the definition of QREs is now directly tied to the figures reported on Line 48 of IRS Form 6765, provided the research was conducted within the borders of Texas.

This federal alignment is a “game-changer” for SMBs that previously spent thousands of dollars on specialized tax consultants to reconcile state and federal definitions. Under the new law, if the IRS accepts a taxpayer’s adjusted Accounting Standards Codification (ASC) 730 financial statement R&D costs, the Texas Comptroller will generally follow suit.

Credit Tier 2025 Rate (Subchapter M) 2026 Rate (Subchapter T) Percentage Increase
Standard Incremental 5.000% 8.722% 74.4%
University-Contracted 6.250% 10.903% 74.4%
New Entrant (Base) 2.500% 4.361% 74.4%
New Entrant (University) 3.125% 5.451% 74.4%

The Refundability Provision for SMBs and Veterans

Recognizing that startups often lack franchise tax liability, SB 2206 introduced a critical refundability provision. A taxable entity is eligible to receive its earned R&D credit as a cash refund if it meets one of three criteria:

  • The entity’s total annualized revenue is not more than $2.47 million (adjusted for inflation).
  • The entity qualifies as a new veteran-owned business.
  • The entity’s computed franchise tax liability is less than $1,000.

While this refundability is a significant improvement over the old system—where pre-revenue companies were forced to carry credits forward for up to 20 years without immediate benefit—it does not address the fundamental timing gap created by the loss of the sales tax exemption.

The Policy Issue: The “Liquidity Trap” for Capital-Intensive Startups

The primary challenge identified in this report is the temporal disconnect between the payment of sales tax and the receipt of the refundable credit. Under the pre-2026 regime, an SMB could claim an immediate exemption at the point of purchase. Under the post-2026 regime, that same SMB must pay the sales tax upfront and then wait until they file their annual franchise tax report—often 12 to 18 months later—to receive a refund.

Cash Flow Burden Analysis

For a capital-intensive startup, such as one developing next-generation semiconductor fabrication techniques or advanced medical diagnostics, the initial investment in equipment is often the largest single expense outside of payroll. The 6.25% to 8.25% tax burden added to these multi-million dollar purchases represents a significant “liquidity trap.”

Consider a hypothetical aerospace startup in DFW purchasing $5 million in specialized testing chambers in February 2026.

  • Under 2025 Rules: The company pays $0 in sales tax, retaining $412,500 (assuming an 8.25% local rate) for operations.
  • Under 2026 Rules: The company must pay $412,500 upfront to the vendor. This cash is locked away until May 2027, when the company files its 2026 franchise tax report and applies for the refundable Subchapter T credit.

This delay creates an opportunity cost that can be fatal for startups. In the venture capital-backed world, a $400,000 cash shortfall can mean the difference between reaching a key technical milestone and running out of runway.

Sector-Specific Sensitivity to Sales Tax Repeal

Certain sectors are disproportionately affected by the loss of the at-purchase exemption due to their high ratio of depreciable equipment costs relative to total QREs.

Industry Sector Typical Equipment Intensity Primary R&D Expense Type Impact of Sales Tax Repeal
Software/SaaS Low Wages (90%+) Negligible (Benefits from 8.722% rate)
Biotechnology High Lab Equipment, Reagents, Supplies Significant Upfront Burden
Semiconductors Very High Clean Room Machining, Fabrication Tools Extreme Upfront Burden
Aerospace High Testing Facilities, Specialized Tooling Significant Upfront Burden
Medical Devices Moderate Prototyping Gear, Testing Chambers Moderate Upfront Burden

As the data suggests, the move to a pure franchise tax credit system inherently favors “labor-heavy” R&D (like software development) while penalizing “asset-heavy” R&D (like manufacturing and life sciences). This creates a policy misalignment with Texas’ stated goal of becoming a global leader in semiconductor manufacturing and biotechnology.

Comparative Policy Landscapes: How Texas Measures Up

To evaluate the risk of innovation flight, we must look at how other states handle the “at-purchase” versus “deferred credit” dilemma. Many states that compete with Texas for high-tech investment have maintained immediate sales tax exemptions for R&D equipment, recognizing the liquidity needs of startups.

State R&D Credit Type Sales Tax Exemption Status Refundability for Startups
Texas (2026) 8.722% (Incremental) Repealed Yes (Revenue < $2.47M)
Indiana 15% (Up to $1M) 100% Exemption (Point of Sale) No (Carryforward only)
Maine 5% (Incremental) 100% Exemption (Point of Sale) No (Carryforward only)
Virginia Up to $45k (Fixed) 100% Exemption (Point of Sale) Yes
California 15% (Incremental) Partial Exemption (3.9375%) No (Carryforward only)
Michigan 10% (Incremental) Repealed/Limited Yes

While Texas now offers a higher rate of credit than many peers, the lack of an immediate exemption puts it at a disadvantage for “Seed” and “Series A” stage companies that are most sensitive to upfront costs. The risk is that these companies will perform their initial capital-intensive research in states with immediate exemptions and only migrate to Texas once they reach the commercial production phase—at which point the most valuable intellectual property has already been developed elsewhere.

Proposed Solution 1: The Texas R&D Accelerated Refund Program (TARP)

To resolve the liquidity trap while adhering to the administrative streamlining goals of SB 2206, the Texas Legislature should implement an Accelerated Refund Program specifically for sales taxes paid on R&D equipment.

Mechanism of TARP

Under this proposal, rather than waiting for the annual franchise tax cycle, qualifying SMBs would be permitted to file for a refund of state and local sales taxes paid on R&D equipment on a quarterly basis.

  • Registration: Businesses would maintain their “RD” registration number with the Comptroller’s office, similar to the existing system.
  • Purchase: The business pays the sales tax at the point of sale, ensuring the state receives the revenue and the vendor’s compliance burden is unchanged.
  • Quarterly Claim: Every three months, the business submits a “Request for Accelerated R&D Refund” via the Comptroller’s Webfile system. This claim would include digital copies of invoices and a brief technical narrative.
  • Expedited Processing: The Comptroller’s Audit Division would be mandated to process these “liquidity claims” within 45 days of submission.

Strategic Advantage: TARP provides the best of both worlds: it preserves the “pay-first” model that the Comptroller prefers for oversight, but it shortens the capital-lockup period from 16 months to approximately 90 days. This would significantly reduce the financial stress on high-growth startups without requiring a return to the “inefficient” point-of-sale exemption system.

Proposed Solution 2: The R&D Equipment Sales Tax Deferral Certificate

A second, more innovative solution would be the creation of a “Tax Deferral Certificate” for verified high-impact startups. This would effectively act as a bridge loan from the state to the innovator.

Mechanism of the Deferral Certificate

This program would target startups in specific high-value sectors (e.g., semiconductors, life sciences) that are partnering with Texas higher education institutions.

  • Application: A startup applies for a “Subchapter T Deferral Certificate” by providing proof of a research contract with a Texas university.
  • Utilization: When purchasing equipment, the startup presents this certificate to the vendor. The vendor does not collect the tax but reports the transaction to the Comptroller.
  • Reconciliation: The tax is not “exempted” but “deferred.” At the end of the fiscal year, the startup’s earned Subchapter T franchise tax credit is first applied to extinguish the deferred sales tax liability.
  • Residual: If the earned credit exceeds the deferred tax, the business receives the remainder as a refund or carryforward.

Strategic Advantage: This solution directly encourages the university partnerships that the legislature prioritized in SB 2206. It provides immediate liquidity precisely when it is needed most—at the time of equipment acquisition—while ensuring that the benefit is only finalized once the R&D activity is verified through the annual reporting process.

Implementing Policy with Rigorous Fraud and Wastage Protections

A primary driver for the repeal of the sales tax exemption was the difficulty in policing the “divergent use” of property. Companies would occasionally purchase equipment tax-free under an R&D claim and then immediately move that equipment into commercial manufacturing, which is a taxable use of the property. To protect the state’s resources, any new implementation must include enhanced verification protocols.

Audit Triggers and Verification Procedures

  • Tax Account Reconciliation: Auditors should reconcile sales tax refund claims with the general ledger and federal tax returns to identify inconsistencies.
  • The “Intended Use” Audit: For high-value refunds (e.g., those over $50,000), the Comptroller should conduct a “desk audit” or a virtual site visit to confirm the machinery is installed in a research environment.
  • Four-Part Test Substantiation: Taxpayers must be prepared to provide documentation showing how each piece of equipment was used to eliminate “technical uncertainty” through a “process of experimentation”.
  • Clawback Mechanics: Any policy change should include a statutory “clawback” provision. If equipment is found to be used in a taxable manner within the first two years of purchase, the business should be liable for the original tax plus a 10% penalty and interest.

Utilizing Data Analytics for Fraud Prevention

The state can leverage its “STAR” (State Tax Automated Research) system and federal information-sharing agreements to flag suspicious activity. For example, if a company claims a significant R&D sales tax refund but fails to file a corresponding IRS Form 6765, an automatic audit trigger should be generated.

Verification Tier Claim Value Required Documentation Oversight Action
Low < $10,000 Invoices + RD Number Automated Verification
Moderate $10k – $100k Invoices + Narrative Random Sample Audit
High > $100,000 Full Project Logs + Contracts Mandatory Desk Audit

Cost-Benefit Analysis: Framing R&D Incentives as a Future Revenue Engine

Critics of R&D incentives often point to the immediate “cost” to the General Revenue Fund. For FY 2026–27, the Legislative Budget Board projects that the new R&D credit regime will reduce general revenue by approximately $248 million. However, this figure is misleading if viewed in isolation. When framed as a strategic investment, the program’s long-term benefits far outweigh its initial costs.

The Multiplier Effect: $12.47 for Every $1 Invested

Economic modeling conducted by the Baker Institute at Rice University provides a compelling case for the high return on investment (ROI) of R&D incentives in Texas. Their study found that for every dollar of foregone tax revenue through R&D credits, the State of Texas gains $12.47 in Gross State Product (GSP) over a 20-year period.

Metric Short-Term (1-2 Years) Mid-Term (5-10 Years) Long-Term (20 Years)
State Revenue Outlay High (Upfront refunds) Moderate (Maintenance) Low (Self-sustaining)
GSP Contribution Modest (~$15M in Year 1) High ($748M+ Annually) Extreme ($13.8B Total)
Job Creation Specialized (400-600) Robust (6,000+ Annually) 113,000+ Total Jobs
Tax Base Expansion Minimal Moderate (Property/Payroll) High (Commercial Sales)

How the Program Pays for Itself

  • High-Wage Payroll Recapture: R&D jobs are notoriously high-paying. These employees spend their wages on homes, vehicles, and consumer goods in Texas, all of which generate property and sales tax revenue.
  • Commercialization Spillovers: Successful R&D leads to local manufacturing. When a medical device developed in a Texas lab moves to production, the state collects sales tax on all commercial sales and the supply chain inputs required for manufacturing.
  • Corporate Attraction: A robust R&D ecosystem attracts other companies. As more firms cluster in “Silicon Hills” or the Houston Medical Center, the state’s overall tax base expands without the need for additional rate hikes.

The Importance of the Policy Change and Risks of Inaction

The decision to address the 2026 liquidity gap is not merely a matter of tax technicality; it is a strategic necessity for the future of the Texas economy. As national and global competition for the “next big thing” intensifies, the states that offer the most frictionless environment for innovation will win.

Negative Consequences of Inaction

  • Stifled Startup Formation: Potential founders may look to states like Indiana or Virginia, where they can stretch their initial seed capital further thanks to immediate exemptions.
  • Reduced University Collaboration: Startups may avoid university partnerships if they cannot afford the specialized equipment required to perform the research in the first place, undermining the 10.903% “super-credit” intent.
  • Delayed Breakthroughs: In fields like biotechnology, a 16-month delay in equipment acquisition can mean a 16-month delay in a life-saving drug reaching the market.
  • The “Innovation Gap”: Texas currently ranks 33rd nationally in R&D investment as a percentage of GSP. Failing to solve the liquidity issue will prevent the state from closing this gap, despite being the nation’s second-largest economy.

The Benefits of a Proactive Fix

Conversely, implementing a quarterly refund or deferral program would signal to the global technology community that Texas is serious about being the “Innovation Capital of the World”. It would complement the existing “Texas Enterprise Fund” and “Governor’s University Research Initiative” (GURI) to create a seamless pipeline from lab bench to commercial market.

Conclusion: Securing the Lone Star State’s Innovation Future

The passage of Senate Bill 2206 was a bold and necessary step toward modernizing the Texas tax code. By creating a permanent, enhanced, and federally-aligned R&D franchise tax credit, the state has provided the stability and simplicity that large-scale industrial players require. However, for the state’s most vulnerable and vital economic engine—the pre-revenue, capital-intensive startup—the 2026 repeal of the sales tax exemption represents a significant barrier to entry.

The implementation of an Accelerated Refund Program or a Deferral Certificate mechanism would effectively bridge this liquidity gap without sacrificing the administrative efficiencies gained by the new law. By framing this as a high-ROI investment that yields $12.47 in economic growth for every $1 in initial outlay, the state can justify the temporal revenue shift as a down payment on future prosperity.

Texas has a unique opportunity to lead. While other states struggle with complex, non-refundable, or expiring incentives, Texas can offer a system that is both simple for large corporations and liquid for small entrepreneurs. By making these targeted adjustments before the January 1, 2026, sunset, the Texas Legislature can ensure that the “Texas Miracle” continues to thrive in the knowledge economy of the 21st century.

Works Cited

  1. Texas expands R&D tax credit; ends sales tax exemption – RSM US, accessed on March 16, 2026, https://rsmus.com/insights/tax-alerts/2025/texas-expand-r-d-tax-credit-ends-sales-tax-exemption.html
  2. Texas Legislature Overhauls the Franchise Tax R&D Credit – Reed Smith LLP, accessed on March 16, 2026, https://www.reedsmith.com/articles/texas-legislature-overhauls-the-franchise-tax-r-d-credit/
  3. SUBCHAPTER T FRANCHISE TAX CREDIT FOR RESEARCH AND DEVELOPMENT ACTIVITIES – Texas Comptroller of Public Accounts, accessed on March 16, 2026, https://comptroller.texas.gov/taxes/franchise/research-dev-credit.php
  4. Supplement: TX SB2206 | 2025-2026 | 89th Legislature | Analysis (Enrolled) – LegiScan, accessed on March 16, 2026, https://legiscan.com/TX/supplement/SB2206/id/617266
  5. 83(R) HB 800 – Engrossed version – Fiscal Note – Texas Legislature Online, accessed on March 16, 2026, https://www.legis.state.tx.us/tlodocs/83R/fiscalnotes/html/HB00800E.htm
  6. The digital content on TLO has been updated to align with the accessibility standards required by WCAG 2.1. – Texas Legislature Online, accessed on March 16, 2026, https://capitol.texas.gov/tlodocs/89R/analysis/html/SB02206F.htm
  7. Sales Tax Exemption or Franchise Tax Credit for Qualified Research Prior to Jan. 1, 2026, accessed on March 16, 2026, https://comptroller.texas.gov/taxes/qualified-research/
  8. Texas R&D Tax Credit Services – James Moore, accessed on March 16, 2026, https://www.jmco.com/tax/r-and-d-tax-credit-services/texas/
  9. Franchise Tax Overview – Texas Comptroller, accessed on March 16, 2026, https://comptroller.texas.gov/taxes/publications/98-806.php
  10. Texas enacts law to replace research and development franchise tax credit, repeal sales and use tax exemption – Tax News Update, accessed on March 16, 2026, https://taxnews.ey.com/news/2025-1301-texas-enacts-law-to-replace-research-and-development-franchise-tax-credit-repeal-sales-and-use-tax-exemption
  11. Texas R&D Tax Credits – Strike Tax Advisory, accessed on March 16, 2026, https://www.striketax.com/state-rd-credits/texas-r-d-tax-credits
  12. Texas R&D Tax Credit Gets a Major Upgrade: What Innovative Businesses Need to Know for 2025 – Boast, accessed on March 16, 2026, https://www.boast.ai/en-ca/blog/rd/texas-rd-tax-credit-gets-a-major-upgrade-what-innovative-businesses-need-to-know-for-2025
  13. Texas R&D Tax Credit Updates Enhance Innovation & Planning… – Doeren Mayhew, accessed on March 16, 2026, https://www.doeren.com/viewpoint/texas-r-d-tax-credit-updates-enhance-innovation-planning-opportunities
  14. SB 2206 – Texas State – Legislative Auditor: PoliScore, accessed on March 16, 2026, https://poliscore.us/2026/tx/bill/2160/sb/2206
  15. File the Qualified Research Annual Report – Texas Comptroller of Public Accounts, accessed on March 16, 2026, https://comptroller.texas.gov/help/research-exemption/report.php?category=taxes
  16. Texas Legislation Updates R&D Franchise Tax Credit | Cherry Bekaert, accessed on March 16, 2026, https://www.cbh.com/insights/articles/texas-legislation-updates-rd-franchise-credit/
  17. Texas updates R&D credit, removes sales tax exemption – CohnReznick, accessed on March 16, 2026, https://www.cohnreznick.com/insights/texas-updates-rd-credit-ends-sales-tax-exemption
  18. Texas Provides for New and Improved Research and Development Credit – Ryan, accessed on March 16, 2026, https://ryan.com/about-ryan/news-and-insights/2025/texas-rd-tax-credit-update/
  19. Texas Enacts Law to Enhance R&D Tax Credit – BDO USA, accessed on March 16, 2026, https://www.bdo.com/insights/tax/texas-enacts-law-to-enhance-r-d-tax-credit
  20. Texas extends, strengthens R&D tax credit, securing innovation advantage, accessed on March 16, 2026, https://www.dallaschamber.org/blog/texas-extends-strengthens-rd-tax-credit-securing-innovation-advantage/
  21. 25.141.1618 1 BILL ANALYSIS S.B. 2206 By – Texas Legislature Online, accessed on March 16, 2026, https://capitol.texas.gov/tlodocs/89R/analysis/pdf/SB02206H.pdf
  22. Bill Text: TX SB2206 | 2025-2026 | 89th Legislature | Comm Sub – LegiScan, accessed on March 16, 2026, https://legiscan.com/TX/text/SB2206/id/3242259
  23. SB 2206 – 89th Legislature – Texas Policy Research, accessed on March 16, 2026, https://www.texaspolicyresearch.com/bills/89th-legislature-sb-2206/
  24. State Tax Incentives for Economic Development – Urban Institute, accessed on March 16, 2026, https://www.urban.org/research/publication/state-tax-incentives-economic-development
  25. Texas Taxes & Economic Development Incentives | TxEDC, accessed on March 16, 2026, https://businessintexas.com/why-texas/taxes-incentives/
  26. Technology Tax Credits and Sales Tax Exemptions | Office of Business Development – Maine.gov, accessed on March 16, 2026, https://www.maine.gov/decd/business-development/financial-incentives-resources/technology-tax-credits-sales-tax-exemptions
  27. Appendix F: R&D tax incentives by state – JLARC, accessed on March 16, 2026, https://jlarc.virginia.gov/pdfs/oversight/ED_initiatives/SciTech%20Appendix%20F.pdf
  28. R&D Sales Tax Exemption – IEDC, accessed on March 16, 2026, https://iedc.in.gov/indiana-advantages/investments/r-d-tax-credit/r-d-sales-tax-exemption
  29. State Research and Development Tax Incentives – CCH® AnswerConnect, accessed on March 16, 2026, https://answerconnect.cch.com/topic/9439bc647c761000ad8cd8d385ad169402/state-research-and-development-tax-incentives
  30. Evaluating State and Local Business Incentives – American Economic Association, accessed on March 16, 2026, https://pubs.aeaweb.org/doi/10.1257/jep.34.2.90
  31. Refund Verification and Processing, accessed on March 16, 2026, https://comptroller.texas.gov/taxes/audit/refund.php
  32. Expediting a Refund – Taxpayer Advocate Service – IRS.gov, accessed on March 16, 2026, https://www.taxpayeradvocate.irs.gov/get-help/refunds/expediting-a-refund/
  33. BIOTECHNOLOGY SALES AND USE TAX REFUND | Colorado, accessed on March 16, 2026, https://content.leg.colorado.gov/sites/default/files/te9_biotechnology_sales_and_use_tax_refund.pdf
  34. Press Items: Senator Paul Bettencourt, accessed on March 16, 2026, https://senate.texas.gov/press.php?id=7-20250428a
Notice & Disclaimer: The information is current as of July 28, 2026, and that the report is provided for information purposes only and to seek legal or tax representation to understand how this applies to your own circumstances. This whitepaper is provided for discussion purposes only and to seek legal or tax representation to understand how it would apply to specific circumstances.
Contact Us

Send us a message and we will be in touch shortly!

Start typing and press Enter to search